![Eli Lilly Launches Open Letter about Mounjaro® and Zepbound® Use](/images/el/i-/eli-lilly-launches-open-letter-about-mounjaro-reg-and-zepbound-reg-use.webp)
Eli Lilly Launches Open Letter about Mounjaro® and Zepbound® Use
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.
7939 NW 21st St
Miami, Florida
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.